Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
American Century Non-US IntrsVal Inv ANTUX
- NAV / 1-Day Return 9.32 / +0.65 %
- Total Assets 589.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.190%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 2.70%
- Turnover 62%
USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0
Morningstar’s Analysis ANTUX
Will ANTUX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 36.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
GSK PLC | 4.95 | 30.4 Mil | Healthcare |
SUMCO Corp | 4.29 | 26.3 Mil | Technology |
Sanofi SA | 4.00 | 24.6 Mil | Healthcare |
Roche Holding AG | 3.77 | 23.1 Mil | Healthcare |
British American Tobacco PLC | 3.50 | 21.5 Mil | Consumer Defensive |
Smurfit Kappa Group PLC | 3.44 | 21.1 Mil | Consumer Cyclical |
NN Group NV | 3.32 | 20.4 Mil | Financial Services |
Eiffage SA Bearer and / or registered shares | 3.11 | 19.1 Mil | Industrials |
Reckitt Benckiser Group PLC | 3.06 | 18.8 Mil | Consumer Defensive |
Adecco Group AG | 3.03 | 18.6 Mil | Industrials |